News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,981 Results
Type
Article (1921)
Company Profile (17)
Press Release (91043)
Section
Business (36596)
Career Advice (51)
Deals (5806)
Drug Delivery (4)
Drug Development (10920)
Employer Resources (1)
FDA (1608)
Job Trends (1894)
News (53052)
Policy (2987)
Tag
2027 BioCapital Standard (1)
2027 Pharm Country Standard (1)
Academia (142)
Accelerated approval (15)
ADA (6)
Adcomms (3)
Allergies (27)
Alliances (3520)
ALS (24)
Alzheimer's disease (180)
Antibody-drug conjugate (ADC) (68)
Approvals (1720)
Artificial intelligence (41)
ASCO (52)
Autoimmune disease (37)
Automation (2)
Bankruptcy (19)
Best Places to Work (1781)
Biosimilars (26)
Biotechnology (14)
Bladder cancer (42)
Brain cancer (4)
Breast cancer (126)
Cancer (840)
Cardiovascular disease (72)
Career advice (46)
Career pathing (4)
CAR-T (40)
CDC (11)
Celiac Disease (1)
Cell therapy (85)
Cervical cancer (6)
Clinical research (10379)
Collaboration (129)
Compensation (118)
Complete response letters (4)
COVID-19 (268)
CRISPR (9)
C-suite (55)
Cystic fibrosis (6)
Data (1476)
Decentralized trials (1)
Depression (30)
Dermatology (18)
Diabetes (103)
Diagnostics (1037)
Digital health (6)
Diversity, equity & inclusion (2)
Drug discovery (18)
Drug pricing (13)
Drug shortages (1)
Duchenne muscular dystrophy (45)
Earnings (32793)
Employer resources (2)
Events (13485)
Executive appointments (70)
FDA (2256)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (109)
Gene editing (15)
Gene therapy (57)
GLP-1 (154)
Government (237)
Grass and pollen (1)
Guidances (275)
Healthcare (2437)
Hematology (32)
HIV (12)
Huntington's disease (4)
IgA nephropathy (21)
Immunology and inflammation (32)
Immuno-oncology (8)
Indications (30)
Infectious disease (318)
Inflammatory bowel disease (29)
Influenza (23)
Intellectual property (36)
Interviews (4)
IPO (4314)
IRA (4)
Job creations (203)
Job search strategy (37)
Kidney cancer (4)
Labor market (14)
Layoffs (33)
Leadership (1)
Legal (532)
Liver cancer (11)
Longevity (3)
Lung cancer (131)
Lymphoma (104)
Machine learning (2)
Manufacturing (66)
MASH (49)
Medical device (2197)
Medtech (2222)
Mergers & acquisitions (1664)
Metabolic disorders (243)
mRNA (10)
Multiple sclerosis (20)
NASH (4)
Neurodegenerative disease (43)
Neuropsychiatric disorders (9)
Neuroscience (376)
NextGen: Class of 2026 (609)
Non-profit (278)
Now hiring (6)
Obesity (81)
Opinion (9)
Ovarian cancer (33)
Pain (27)
Pancreatic cancer (29)
Parkinson's disease (30)
Patents (66)
Patient recruitment (69)
Peanut (13)
People (4114)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (2759)
Phase 2 (4378)
Phase 3 (3951)
Pipeline (2610)
Policy (16)
Postmarket research (340)
Preclinical (839)
Press Release (10)
Prostate cancer (60)
Radiopharmaceuticals (50)
Rare diseases (113)
Real estate (328)
Regulatory (2754)
Reports (10)
Research institute (119)
Resumes & cover letters (8)
Rett syndrome (10)
RNA editing (1)
RSV (21)
Schizophrenia (36)
Series A (21)
Series B (11)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (21)
Sponsored (1)
Startups (139)
Stomach cancer (2)
Supply chain (6)
Tariffs (4)
The Weekly (2)
Vaccines (144)
Venture capital (4)
Weight loss (63)
Women's health (12)
Worklife (5)
Date
Today (10)
Last 7 days (66)
Last 30 days (344)
Last 365 days (5092)
2026 (2493)
2025 (5127)
2024 (5894)
2023 (7083)
2022 (8154)
2021 (9632)
2020 (8675)
2019 (5964)
2018 (4500)
2017 (4578)
2016 (3226)
2015 (4955)
2014 (3089)
2013 (1630)
2012 (1979)
2011 (2452)
2010 (2226)
Location
Africa (61)
Alabama (7)
Arizona (36)
Asia (6961)
Australia (919)
California (2330)
Canada (767)
China (155)
Colorado (106)
Connecticut (109)
Delaware (91)
Europe (11041)
Florida (332)
Georgia (70)
Idaho (2)
Illinois (157)
India (7)
Indiana (201)
Japan (95)
Kansas (33)
Kentucky (23)
Louisiana (17)
Maine (16)
Maryland (332)
Massachusetts (1569)
Michigan (47)
Minnesota (115)
Missouri (29)
Montana (11)
Nebraska (2)
Nevada (13)
New Hampshire (10)
New Jersey (755)
New York (773)
North Carolina (254)
Northern California (1169)
Ohio (46)
Oklahoma (1)
Oregon (3)
Pennsylvania (535)
Puerto Rico (13)
Rhode Island (3)
South America (124)
South Carolina (2)
Southern California (993)
Tennessee (14)
Texas (310)
United States (8468)
Utah (84)
Virginia (71)
Washington D.C. (6)
Washington State (177)
Wisconsin (13)
92,981 Results for "64".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
April 28, 2026
·
3 min read
Press Releases
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
June 11, 2026
·
13 min read
Press Releases
New York Proton Center Presents Advances in Proton Therapy Across Multiple Cancers at PTCOG 64
June 11, 2026
·
5 min read
Press Releases
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
·
6 min read
Press Releases
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
May 13, 2026
·
10 min read
Press Releases
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
·
1 min read
Press Releases
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
May 29, 2026
·
4 min read
Press Releases
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
January 19, 2026
·
6 min read
Press Releases
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
March 20, 2026
·
2 min read
Press Releases
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 21, 2026
·
6 min read
1 of 9,299
Next
